SCHEMBL16166368

SCHEMBL16166368

N=C(N)c1ccc(N)cc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.57
KDM4E B2RXH2 4/20 0.57
ALDH1A1 P00352 4/20 0.57
CYP3A4 P08684 3/20 0.57
GAA P10253 2/20 0.57
ESR2 Q92731 1/20 0.57
PTPN1 P18031 1/20 0.57
TDP1 Q9NUW8 3/20 0.53
POLB P06746 1/20 0.53
CASP1 P29466 2/20 0.46
TSHR P16473 1/20 0.46
PLAU P00749 3/20 0.44
KDR P35968 2/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
TBXA2R P21731 1/20 0.44
SLC6A2 P23975 1/20 0.44
PDE4A P27815 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28013376 0.79 CES2 (0.54) MAPTKDM4EALDH1A1CYP3A4GAA
Aminosalicylic Acid SCHEMBL9949357 0.78 ALDH1A1 (0.92) MAPTKDM4EALDH1A1CYP3A4GAA
SCHEMBL1526264 0.77 MAPT (0.69) MAPTKDM4EALDH1A1CYP3A4GAA
SCHEMBL23176329 0.76 PLAU (0.43) MAPTKDM4EALDH1A1CYP3A4GAA
SCHEMBL27758947 0.76 ALDH1A1 (0.50) MAPTKDM4EALDH1A1CYP3A4GAA
SCHEMBL17826825 0.76 ERN1 (0.36) MAPTKDM4EALDH1A1CYP3A4GAA
SCHEMBL5746471 0.76 CA3 (0.48) ALDH1A1ESR2PLAULMNASMN1; SMN2
SCHEMBL24314179 0.76 C1S (0.45) MAPTKDM4EGAACASP1PLAU
SCHEMBL5260076 0.76 F2 (0.55) MAPTALDH1A1GAATDP1PLAU
SCHEMBL13448267 0.76 PLAU (0.55) MAPTKDM4EALDH1A1CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2978750-A2 \"SYNTHESIS OF DABIGATRAN\ USV Limited (IN) 2016-02-03 EP claimed
WO-2014167577-A2 \"SYNTHESIS OF DABIGATRAN\ USV LIMITED (IN) 2014-10-16 WO claimed
CN-105523999-B Synthesis method of dabigatran etexilate intermediate 重庆医药工业研究院有限责任公司 2020-04-24 CN disclosed
EP-2978750-A2 \"SYNTHESIS OF DABIGATRAN\ USV Limited (IN) 2016-02-03 EP disclosed
WO-2014167577-A2 \"SYNTHESIS OF DABIGATRAN\ USV LIMITED (IN) 2014-10-16 WO disclosed